Drug
Ksi 101
Ksi 101: highest development phase Phase 3, developed by Kodiak Sciences. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kodiak Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| KSI-101 NCT06990399 | Phase 3 | Macular Edema Secondary to Inflammation |
| KSI-101 NCT06996080 | Phase 3 | Macular Edema Secondary to Inflammation |
Latest
No recent events.
Follow Ksi 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.